Misuse of the well-stirred model of hepatic drug clearance
- PMID: 17325025
- DOI: 10.1124/dmd.106.013359
Misuse of the well-stirred model of hepatic drug clearance
Similar articles
-
Hepatic circulation and drug disposition in cirrhosis.Gastroenterology. 1979 Jul;77(1):185-6. Gastroenterology. 1979. PMID: 447017 No abstract available.
-
Clearance and biologic half-life as indices of intrinsic hepatic metabolism.J Pharmacol Exp Ther. 1974 Oct;191(1):17-24. J Pharmacol Exp Ther. 1974. PMID: 4423599 No abstract available.
-
Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.Drug Metab Dispos. 1984 Jul-Aug;12(4):385-8. Drug Metab Dispos. 1984. PMID: 6148202 No abstract available.
-
Drug administration in hepatic disease.N Engl J Med. 1983 Dec 29;309(26):1616-22. doi: 10.1056/NEJM198312293092605. N Engl J Med. 1983. PMID: 6358891 Review. No abstract available.
-
Clearance approaches in pharmacology.Pharmacol Rev. 1987 Mar;39(1):1-47. Pharmacol Rev. 1987. PMID: 3554275 Review. No abstract available.
Cited by
-
Precision Dosing Management with Intelligent Computing in Digital Health.Proc Int Conf Intell Netw Collab Syst. 2020 Aug-Sep;1263:269-280. doi: 10.1007/978-3-030-57796-4_26. Epub 2020 Aug 21. Proc Int Conf Intell Netw Collab Syst. 2020. PMID: 37915763 Free PMC article.
-
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin.Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0043023. doi: 10.1128/aac.00430-23. Epub 2023 Oct 18. Antimicrob Agents Chemother. 2023. PMID: 37850738 Free PMC article. Clinical Trial.
-
Preclinical Pharmacokinetics and Translational Pharmacokinetic/Pharmacodynamic Modeling of M8891, a Potent and Reversible Inhibitor of Methionine Aminopeptidase 2.Pharm Res. 2023 Dec;40(12):3011-3023. doi: 10.1007/s11095-023-03611-z. Epub 2023 Oct 5. Pharm Res. 2023. PMID: 37798538 Free PMC article.
-
Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate.Eur J Drug Metab Pharmacokinet. 2023 Nov;48(6):619-621. doi: 10.1007/s13318-023-00859-z. Epub 2023 Oct 4. Eur J Drug Metab Pharmacokinet. 2023. PMID: 37792131 No abstract available.
-
Using Prior Knowledge on Systems Through PBPK to Gain Further Insight into Routine Clinical Data on Trough Concentrations: The Case of Tacrolimus in Chronic Kidney Disease.Ther Drug Monit. 2023 Dec 1;45(6):743-753. doi: 10.1097/FTD.0000000000001108. Epub 2023 Jun 13. Ther Drug Monit. 2023. PMID: 37315152 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources